Hess, B., Hill, E. G., Hendrickson, L., Armeson, K., Oberholtzer, N., Duke, T., McGann, M., Davis, J. A., Antel, K., Gurumurthi, A., Alhousani, M., Goodwin, S., Pearce, L., Burke, B., Kryway, E., Stiff, P. J., Hossain, N. M., Scurti, G., Nishimura, M., Mehrotra, S. (2026). Phase 1 dose escalation study of CD34 selected CD19 directed CAR T with metabolic programming in relapsed/refractory B-cell lymphoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.2544